BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 29048621)

  • 1. Irisin reverses the IL-6 induced epithelial-mesenchymal transition in osteosarcoma cell migration and invasion through the STAT3/Snail signaling pathway.
    Kong G; Jiang Y; Sun X; Cao Z; Zhang G; Zhao Z; Zhao Y; Yu Q; Cheng G
    Oncol Rep; 2017 Nov; 38(5):2647-2656. PubMed ID: 29048621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitidine chloride suppresses epithelial-to-mesenchymal transition in osteosarcoma cell migration and invasion through Akt/GSK-3β/Snail signaling pathway.
    Cheng Z; Guo Y; Yang Y; Kan J; Dai S; Helian M; Li B; Xu J; Liu C
    Oncol Rep; 2016 Aug; 36(2):1023-9. PubMed ID: 27279040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irisin suppresses the migration, proliferation, and invasion of lung cancer cells via inhibition of epithelial-to-mesenchymal transition.
    Shao L; Li H; Chen J; Song H; Zhang Y; Wu F; Wang W; Zhang W; Wang F; Li H; Tang D
    Biochem Biophys Res Commun; 2017 Apr; 485(3):598-605. PubMed ID: 27986567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
    Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
    Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
    Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visfatin promotes osteosarcoma cell migration and invasion via induction of epithelial-mesenchymal transition.
    Cheng G; Liu C; Sun X; Zhang L; Liu L; Ouyang J; Li B
    Oncol Rep; 2015 Aug; 34(2):987-94. PubMed ID: 26062797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways.
    Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T
    Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.
    Esparza-López J; Alvarado-Muñoz JF; Escobar-Arriaga E; Ulloa-Aguirre A; de Jesús Ibarra-Sánchez M
    BMC Cancer; 2019 Jul; 19(1):728. PubMed ID: 31337349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tim-3 facilitates osteosarcoma proliferation and metastasis through the NF-κB pathway and epithelial-mesenchymal transition.
    Feng ZM; Guo SM
    Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-myc downstream-regulated gene 2 (NDRG2) suppresses the epithelial-mesenchymal transition (EMT) in breast cancer cells via STAT3/Snail signaling.
    Kim MJ; Lim J; Yang Y; Lee MS; Lim JS
    Cancer Lett; 2014 Nov; 354(1):33-42. PubMed ID: 25153349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects and mechanisms of blockage of STAT3 signaling pathway on IL-6 inducing EMT in human pancreatic cancer cells in vitro.
    Huang C; Yang G; Jiang T; Zhu G; Li H; Qiu Z
    Neoplasma; 2011; 58(5):396-405. PubMed ID: 21744993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of microRNA-145 promotes epithelial-mesenchymal transition via regulating Snail in osteosarcoma.
    Zhang Z; Zhang M; Chen Q; Zhang Q
    Cancer Gene Ther; 2017 Feb; 24(2):83-88. PubMed ID: 28186090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling.
    Huang SY; Chang SF; Liao KF; Chiu SC
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway.
    Zhang H; Sun JD; Yan LJ; Zhao XP
    Biochem Biophys Res Commun; 2016 Sep; 478(2):845-51. PubMed ID: 27507215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PMA treated THP-1-derived-IL-6 promotes EMT of SW48 through STAT3/ERK-dependent activation of Wnt/β-catenin signaling pathway.
    Gao S; Hu J; Wu X; Liang Z
    Biomed Pharmacother; 2018 Dec; 108():618-624. PubMed ID: 30243096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGF induces epithelial-mesenchymal transition through phospho-Smad2/3-Snail signaling pathway in breast cancer cells.
    Kim J; Kong J; Chang H; Kim H; Kim A
    Oncotarget; 2016 Dec; 7(51):85021-85032. PubMed ID: 27829223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting STAT3/miR-21 axis inhibits epithelial-mesenchymal transition via regulating CDK5 in head and neck squamous cell carcinoma.
    Sun SS; Zhou X; Huang YY; Kong LP; Mei M; Guo WY; Zhao MH; Ren Y; Shen Q; Zhang L
    Mol Cancer; 2015 Dec; 14():213. PubMed ID: 26690371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon consensus sequence-binding protein (ICSBP) promotes epithelial-to-mesenchymal transition (EMT)-like phenomena, cell-motility, and invasion via TGF-β signaling in U2OS cells.
    Sung JY; Park SY; Kim JH; Kang HG; Yoon JH; Na YS; Kim YN; Park BK
    Cell Death Dis; 2014 May; 5(5):e1224. PubMed ID: 24832596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-2 induces extracellular matrix synthesis and TGF-β2 expression in retinal pigment epithelial cells.
    Jing R; Qi T; Wen C; Yue J; Wang G; Pei C; Ma B
    Dev Growth Differ; 2019 Sep; 61(7-8):410-418. PubMed ID: 31608440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.